Fellowships: Oncological Sciences – F07B
The F07B panel reviews fellowship applications dealing with basic, translational, and clinical science in cancer immunology and immunotherapy of cancer. It encompasses scientific disciplines covered by the Cellar Immunotherapy of Cancer (CIC) scientific review group and a subset of disciplines covered by the Translational Immune Oncology and (TIO) and Therapeutic Immune regulation (TIR) scientific review groups.
Review Dates
- Adoptive cellular therapies (tumor-infiltrating lymphocytes, chimeric antigen receptor and T cell receptor-engineered T cells, natural killer cells)
- Computational approaches for new target discovery and novel technologies for studying cancer immunobiology
- Immune modulating drug development
- Abscopal effects of local tumor treatments like radiation, ultrasound, and intra-tumoral injections that promote systemic anti-tumor immune responses.
- Mechanisms of tumor resistance to immunotherapies and/or tumor escape from immune recognition and killing, including modulation of tumor antigen processing and presentation, alteration of tumor susceptibility to innate and adaptive immune responses, tumor-induced immune suppression, and immune effector cell tolerance/exhaustion.
Shared Interests and Overlaps:
The three fellowship study sections covering infectious diseases, microbiology and immunology (F07A, F07B and F07C) are broad in scope and cover substantially equivalent areas of science, with the final assignment made by the staff at the Center for Scientific Review to ensure that each application has the appropriate expertise in bacterial (F07A), viral or fungal (F07C) or immunology and other infectious diseases (except in F07A or F07C) topics (F07B) to review it.
There are shared interests with Oncological Sciences C (F09C). Fellowship applications with an emphasis on translational aspects, such as prevention, diagnosis, development and evaluation of therapeutic strategies may be reviewed by F09, whereas applications focusing on mechanistic immunological aspects, such as the innate and adaptive immune responses to tumor cells may be reviewed here.
There are shared interests with Cell Biology, Developmental Biology and Bioengineering (F05). Fellowship applications with focus on biomaterials development as delivery vectors, computational bioengineering, stem cell biology, or basic principles of cell biology may be reviewed by F05, whereas applications focusing on immunological aspects, such as innate and adaptive immune mechanisms underlying vaccine development or lymphocyte development may be reviewed here.
Fellowship applications with a biological focus on HIV/AIDS are reviewed in HIV/AIDS Biological (F17A).
